International Assets Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

International Assets Investment Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-798	Closed	-$15K	–	1740
2021 Q1	$15K	Buy	798 +209	+35%	+$3.76K	﹤0.01%	1426
2020 Q4	$11K	Buy	+589	New	+$10.3K	﹤0.01%	1402

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

International Assets Investment Management's TAK Position: Q2 2021 in Review

International Assets Investment Management sold out of Takeda Pharmaceutical (TAK) in Q2 2021, closing a stake of 798 shares — an estimated $15K sold.

International Assets Investment Management first reported a position in TAK in Q4 2020 and held it in 2 quarters. The position peaked at $15K in Q1 2021. 305 funds tracked by Wall St. Rank hold TAK as of Q2 2021.

International Assets Investment Management reported no remaining Takeda Pharmaceutical position as of Q2 2021 after selling out during the quarter.
International Assets Investment Management sold 798 Takeda Pharmaceutical shares in Q2 2021, an estimated $15K.
International Assets Investment Management first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 2 quarters.
International Assets Investment Management's Takeda Pharmaceutical position peaked at $15K in Q1 2021.
305 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.